secwatch.observer — SEC 8-K summary
======================================

Issuer:     Cyclerion Therapeutics, Inc. (CYCN)
CIK:        0001755237
Form:       8-K
Filed at:   2025-05-07T23:59:59+00:00
Accession:  0001193125-25-115089
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Cyclerion enters $20M ATM equity distribution agreement with Guggenheim
-----------------------------------------------------------------------

- Entered Sales Agreement with Guggenheim Securities for at-the-market offering of up to $20M of common stock.
- Guggenheim will receive 3% commission on gross proceeds; sales limited by public float under Instruction I.B.6.
- Company has not sold any securities under Instruction I.B.6 in prior 12 months; current public float below $75M.
- Legal opinion from Ropes & Gray covers sale of up to $2,994,080 of Shares under the agreement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1755237/000119312525115089/0001193125-25-115089-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1755237/000119312525115089/d51125d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-115089

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer